Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage ...

Forward Looking Statements: This new release contains "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of ...

Agnico Eagle Mines Limited (AEM) Presents at Emerging Growth Conference 88 Transcript

Emerging Growth Conference 88 December 11, 2025 9:05 AM ESTCompany ParticipantsJean-Marie Clouet - Vice President ...

Nnena Kalu has won the 2025 Turner prize – working with her has inspired my work and academic research

Nnena Kalu’s win shows how contemporary art can be more inclusive if more facilitation, like that provided by ActionSpace, ...

Q2 Metals Announces Results of AGM and Year-End Webcast

Q2 Metals will host a live year-end webcast presentation on Thursday, December 18 at 08:00 AM PST (11:00 AM EST). Management will review the Company’s 2025 performance, highlight upcoming catalysts, ...
MyHorryNews

Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ...

Vor Biopharma: J.P. Morgan Makes Bull Case After Corporate Actions Slam Stock Price

Discover Vor BiopharmaVor Biopharma Inc.'s potential with telitacicept amid funding challenges and market risks. Click for ...